HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.

Abstract
Mice immunized with neuroantigens in incomplete Freund's adjuvant (IFA) are resistant to subsequent induction of experimental autoimmune encephalomyelitis (EAE). The mechanisms involved in this protection are complex. Studies on relevant CD4(+) or CD8(+) T cells, including effective and regulatory T cells, have been performed by others. In this work, the effects of CD4(-)-, CD8(-)- splenocytes on protection from EAE in C57BL/6 mice which were immunized with myelin oligodendrocyte glycoprotein 35-55 (MOG)35-55 in IFA were evaluated. We observed that MOG-reactive CD4(+) T cells failed to be activated and proliferate when CD4(-)-, CD8(-)- splenocytes from MOG/IFA-immunized mice were regarded as antigen-presenting cells (APC). It was shown that these APC expressed lower levels of major histocompatibility complex class II (MHC-II), CD80, and CD86 than naïve cells. In addition, CD4(-)-, CD8(-)- splenocytes from MOG/IFA-immunized mice showed significantly higher levels of IL-10 mRNA expression. When the immunized-mice were induced to develop EAE, these cells secreted significantly higher levels of IL-10 and produced lower levels of IL-6, leading to decreased secretion of IL-17 and IFN-γ from MOG-specific CD4(+) T cells. The transfer of CD4(-)-, CD8(-)- splenocytes from MOG/IFA-immunized mice was able to ameliorate the subsequent induction of EAE in recipient mice. Thus, MOG/IFA immunization can modulate CD4(-)-, CD8(-)- splenocytes by reducing the expression of antigen-presenting molecules and altering the levels of secreted cytokines. Our study reveals an additional mechanism involved in the protective effects of MOG/IFA pre-immunization in an EAE model.
AuthorsHui Zheng, Han Zhang, Feng Liu, Yuanyuan Qi, Hong Jiang
JournalImmunology letters (Immunol Lett) 2014 Jan-Feb Vol. 157 Issue 1-2 Pg. 38-44 ISSN: 1879-0542 [Electronic] Netherlands
PMID24220208 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Antigens
  • Antigens, Surface
  • Cytokines
  • Lipids
  • Myelin-Oligodendrocyte Glycoprotein
  • Peptide Fragments
  • incomplete Freund's adjuvant
  • myelin oligodendrocyte glycoprotein (35-55)
  • Freund's Adjuvant
Topics
  • Adoptive Transfer
  • Animals
  • Antigen Presentation (immunology)
  • Antigen-Presenting Cells (immunology)
  • Antigens (immunology)
  • Antigens, Surface (immunology, metabolism)
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • Cytokines (biosynthesis)
  • Encephalomyelitis, Autoimmune, Experimental (immunology, prevention & control)
  • Freund's Adjuvant (immunology)
  • Immunization
  • Lipids (immunology)
  • Lymphocyte Activation (immunology)
  • Lymphocyte Depletion
  • Male
  • Mice
  • Myelin-Oligodendrocyte Glycoprotein (immunology)
  • Peptide Fragments (immunology)
  • Spleen (cytology, immunology)
  • T-Lymphocyte Subsets (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: